We have worked with some of the most influential people in the world. Click to see what other professionals and global entrepreneurs have said about Beto Paredes.
Through in-house development and joint ventures we currently engineer innovative technologies and services specialized in the medical industry.
THE INDUSTRY STANDARD MANAGEMENT SYSTEM FOR ANS TESTING MEDICAL DEVICES. INTEGRATED WITH RM-3A AND TM-FLOW
PECE Platform was developed through industry experts and the LABS engineering division of the Beto Paredes Family of Companies. This is an enterprise management system that works with all required staff members and multiple locations. All users have the ability to collaborate on medical device reporting data and billing.
PECE operates through custom-engineered algorithms built to read biomedical informatic data from various reporting methods and display validated medical information. We have coded the LCD requirements and qualify encounter form and billing submissions directly from the reporting data. We fully prepare encounter data for physician review and digital signature. Unique to our system we qualify medical necessity diagnostic data leading to “next step analysis” across 21 additional exams (MRI, nerve conduction study etc…). We are currently servicing dozens of happy practice customers.
THE INDUSTRY STANDARD MANAGEMENT SYSTEM FOR THE ELECTRIC CELL SIGNALING MEDICINE. INTEGRATED WITH neoGEN AND TM-FLOW
Bioenergetics was developed through industry experts and the LABS engineering division of the Beto Paredes Family of Companies. This is an enterprise management system that works with all required staff members and multiple locations. All users have the ability to collaborate on medical device reporting data and billing.
Bioenergetics operates through custom-engineered treatment plans and algorithms built to manage long term treatment protocol and display validated medical information. We have coded the LCD requirements and qualify encounter form and billing data directly from the reporting data. We fully prepare encounter data for physician review and digital signature. Our management system was developed in collaboration with one of the largest medical device manufacturers in the United States. They currently have 8,000 electric cell signaling devices in the field.
MASSIVE MEDICAL INVENTORY MANAGEMENT FOR THE SALE OF MEDICAL DEVICES, EQUIPMENT AND MEDICAL SUPPLIES INTERNATIONALLY
MedWorldOne.com was developed through a JV Partnership with World Scientific and the LABS engineering division of the Beto Paredes Family of Companies. Our platform facilitates the procurement of used and nearly expired medical equipment from hospitals, diagnostic centers, medical facilities and distributors into an online marketplace.
The MedWorldOne.com international business model exposes valuable medical equipment to an international consortium of partnerships. The demand side market of governments, hospitals and other medical facilities worldwide can search and buy equipment directly on our platform. We work with every size of buyer. Our services include access to consultants that source large scale hospital furnishing and equipment needs and prepare full build quotes. Direct distributors can also build in accounts and sell at controlled prices. This project started in 2020 and MedWorldOne.com is set to launch in May 2022.
GLOBAL INITIATIVE IN MEDICAL DATA COLLECTION, REPORTING AND TRENDING FOR INTERNATIONAL GOVERNMENT HEALTH CARE SYSTEMS
DataMed Unlimited is a global initiative combining cutting edge medical device and laboratory solutions in joint venture projects with governments. Utilizing blood card technology for in-home laboratory testing and mobile facilities with ANS testing our programs can assess large populations in record time.
DataMed’s back office system analyzes over 120 medical bio markers and a large variety of lab assays and prepares patient records of results. These results become accessible to the larger population of doctors, hospitals and medical facilities that have access to the patient data. For government health administrations the data collected can be accessed for disease state and symptom trending within chosen populations. This facilitates their ability to make much better decisions about the health care of their people for the development of future programs. We have currently submitted proposals and plan to launch in 2023.